Welch & Forbes’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,338
Closed -$394K 358
2019
Q3
$394K Sell
2,338
-2,190
-48% -$357K 0.01% 282
2019
Q2
$759K Sell
4,528
-12,655
-74% -$1.75M 0.02% 223
2019
Q1
$2.52M Sell
17,183
-3,366
-16% -$488K 0.06% 159
2018
Q4
$2.75M Sell
20,549
-2,180
-10% -$357K 0.08% 145
2018
Q3
$4.33M Sell
22,729
-545
-2% -$100K 0.1% 135
2018
Q2
$3.88M Sell
23,274
-694
-3% -$111K 0.1% 136
2018
Q1
$4.03M Sell
23,968
-358
-1% -$60K 0.1% 138
2017
Q4
$3.98M Buy
+24,326
New +$4.37M 0.11% 133
2017
Q1
Sell
-34,766
Closed -$7.3M 357
2016
Q4
$7.3M Sell
34,766
-32,467
-48% -$6.73M 0.22% 106
2016
Q3
$15.5M Sell
67,233
-1,457
-2% -$356K 0.54% 66
2016
Q2
$15.9M Buy
68,690
+9,663
+16% +$2.23M 0.48% 71
2016
Q1
$15.8M Buy
59,027
+22,712
+63% +$6.5M 0.49% 69
2015
Q4
$11.3M Buy
36,315
+9,704
+36% +$2.89M 0.36% 87
2015
Q3
$7.23M Buy
26,611
+1,872
+8% +$575K 0.24% 101
2015
Q2
$7.51M Buy
24,739
+6,993
+39% +$2.09M 0.23% 98
2015
Q1
$5.28M Buy
17,746
+15,299
+625% +$4.36M 0.16% 126
2014
Q4
$630K Hold
2,447
0.02% 242
2014
Q3
$590K Buy
+2,447
New +$548K 0.02% 246

Other funds holding AGN

Welch & Forbes's AGN Position: Q4 2019 in Review

Welch & Forbes sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 2,338 shares — an estimated $394K sold.

Welch & Forbes first reported a position in AGN in Q3 2014 and held it in 18 quarters. The position peaked at $15.9M in Q2 2016. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Welch & Forbes reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Welch & Forbes sold 2,338 Allergan plc shares in Q4 2019, an estimated $394K.
  • Welch & Forbes first reported a position in Allergan plc in Q3 2014 and held it in 18 quarters.
  • Welch & Forbes's Allergan plc position peaked at $15.9M in Q2 2016.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Welch & Forbes's 13F filing for Q4 2019, filed 17 Jan 2020.